Detalhe da pesquisa
1.
Diagnostic accuracy of a three-protein signature in women with suspicious breast lesions: a multicenter prospective trial.
Breast Cancer Res
; 25(1): 20, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788595
2.
Considerations in Oncoplastic Surgery.
Adv Exp Med Biol
; 1187: 525-544, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33983598
3.
Asprosin attenuates insulin signaling pathway through PKCδ-activated ER stress and inflammation in skeletal muscle.
J Cell Physiol
; 234(11): 20888-20899, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30997682
4.
Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer.
BMC Cancer
; 16: 430, 2016 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27388210
5.
Recurrent fusion transcripts detected by whole-transcriptome sequencing of 120 primary breast cancer samples.
Genes Chromosomes Cancer
; 54(11): 681-91, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26227178
6.
The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean Women.
Ann Surg Oncol
; 22(11): 3481-8, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25652052
7.
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR).
BMC Cancer
; 14: 170, 2014 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24612502
8.
Prognosis and Adjusting Factors in Elderly Patients With Triple-Negative Breast Cancer: Comparing With Young and Middle Age Groups.
Clin Breast Cancer
; 24(4): e258-e265, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38413338
9.
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study.
Expert Opin Biol Ther
; 24(4): 305-312, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38664937
10.
Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority Trial.
J Breast Cancer
; 27(1): 61-71, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38433091
11.
Prognostic effect of preoperative serum estradiol level in postmenopausal breast cancer.
BMC Cancer
; 13: 503, 2013 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24160328
12.
The effects of music therapy on the psychological status of women with perimenopause syndrome.
Menopause
; 30(10): 1045-1052, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37643387
13.
Obstetric and psychiatric history as predictors for psychosomatic symptoms among Korean perimenopausal women.
Maturitas
; 178: 107827, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37659129
14.
Mutational Analysis of Triple-Negative Breast Cancer Using Targeted Kinome Sequencing.
J Breast Cancer
; 25(3): 164-177, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657000
15.
The clinical impact of extrathyroidal extensions on prognoses in pediatric differentiated thyroid cancers.
J Pediatr Surg
; 57(8): 1532-1537, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758908
16.
Clinicopathologic factors affecting discrepancies in HER2 overexpression between core needle biopsy and surgical biopsy in breast cancer patients according to neoadjuvant treatment or not.
J Cancer
; 12(15): 4722-4728, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34149935
17.
Target Calorie Intake Achievements for Patients Treated in the Surgical Intensive Care Unit.
Clin Nutr Res
; 10(2): 107-114, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33987137
18.
A Randomized Controlled Trial for Doing vs. Omitting Intraoperative Frozen Section Biopsy for Resection Margin Status in Selected Patients Undergoing Breast-Conserving Surgery (OFF-MAP Trial).
J Breast Cancer
; 24(6): 569-577, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34979601
19.
Risk Factors for Tamoxifen-Induced Ovarian Hyperstimulation in Breast Cancer Patients.
Clin Breast Cancer
; 20(5): 408-412, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32727665
20.
Programmed cell death-ligand 1 expression in stromal immune cells is a marker of breast cancer outcome.
J Cancer
; 11(24): 7246-7252, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33193888